Roivant Development Code News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roivant development code. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roivant Development Code Today - Breaking & Trending Today

Eisai Enters Into Exclusive Licensing Agreement with Roivant Concerning Investigational Anticancer Agent H3B-8800, a Splicing Modulator

TOKYO, Jan 6, 2022 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into a License Agreement granting the exclusive rights for global research, development, manufacture and sale of the investigational anticancer agent H3B-8800 to a subsidiary of Roivant Sciences Ltd. (Nasdaq: ROIV). H3B-8800 (Roivant's Development Code: RVT-2001) is a splicing modulator compound, discovered by Eisai's. ....

United Kingdom , United States , Eisai Co Ltd , Roivant Development Code , Biomedicine Inc , Roivant Sciences Ltd , Eisai Inc , Public Relations Department , License Agreement , Roivant Sciences , Development Code , Somatic Mutational Landscape , Splicing Factor Genes , Their Functional Consequences , Cell Reports , Relations Department ,